186 related articles for article (PubMed ID: 7515265)
1. Endogenous haemopoietic growth factors in neutropenia and infection.
Cebon J; Layton JE; Maher D; Morstyn G
Br J Haematol; 1994 Feb; 86(2):265-74. PubMed ID: 7515265
[TBL] [Abstract][Full Text] [Related]
2. Differential alterations in plasma colony-stimulating factor concentrations in meningococcaemia.
Waring PM; Presneill J; Maher DW; Layton JE; Cebon J; Waring LJ; Metcalf D
Clin Exp Immunol; 1995 Dec; 102(3):501-6. PubMed ID: 8536364
[TBL] [Abstract][Full Text] [Related]
3. Regulated plasma levels of colony-stimulating factors, interleukin-6 and interleukin-10 in patients with acute leukaemia and non-hodgkin's lymphoma undergoing cytoreductive chemotherapy.
Reisbach G; Kamp T; Welzl G; Geiz C; Abedinpour Fariborz ; Lodri A; Kaboth W; Dörmer P; Nerl C
Br J Haematol; 1996 Mar; 92(4):907-12. PubMed ID: 8616084
[TBL] [Abstract][Full Text] [Related]
4. Plasma granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in critical illness including sepsis and septic shock: relation to disease severity, multiple organ dysfunction, and mortality.
Presneill JJ; Waring PM; Layton JE; Maher DW; Cebon J; Harley NS; Wilson JW; Cade JF
Crit Care Med; 2000 Jul; 28(7):2344-54. PubMed ID: 10921563
[TBL] [Abstract][Full Text] [Related]
5. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) in serum during induction treatment of acute leukaemia.
Sallerfors B; Olofsson T
Br J Haematol; 1991 Jul; 78(3):343-51. PubMed ID: 1714757
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
Bruserud O; Foss B; Petersen H
Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
[TBL] [Abstract][Full Text] [Related]
7. Adhesion molecules, endogenous granulocyte colony-stimulating factor levels and replating capacity of progenitors in autoimmune neutropenia of childhood.
Perdikogianni Ch; Dimitriou H; Stiakaki E; Markaki EA; Kalmanti M
Acta Paediatr; 2003 Nov; 92(11):1277-83. PubMed ID: 14696847
[TBL] [Abstract][Full Text] [Related]
8. Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors.
Mayordomo JI; Rivera F; Díaz-Puente MT; Lianes P; Colomer R; López-Brea M; López E; Paz-Ares L; Hitt R; García-Ribas I
J Natl Cancer Inst; 1995 Jun; 87(11):803-8. PubMed ID: 7540696
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of G-CSF, M-CSF and GM-CSF in a patient with cyclic neutropenia.
Misago M; Kikuchi M; Tsukada J; Hanamura T; Kamachi S; Eto S
Eur J Haematol; 1991 May; 46(5):312-3. PubMed ID: 1710576
[No Abstract] [Full Text] [Related]
10. Recombinant human granulocyte-macrophage colony-stimulating factor therapy and endogenous plasma GM-CSF, IL-3, IL-4 concentrations in pediatric patients with solid tumors.
Cetingül N; Kütükçüler N; Kantar M; Kavakli K; Nişli G; Cağlayan S; Oztop S
Turk J Pediatr; 1997; 39(4):473-81. PubMed ID: 9433149
[TBL] [Abstract][Full Text] [Related]
11. Prospective randomized comparison of morning versus night daily single subcutaneous administration of granulocyte-macrophage-colony stimulating factor in patients with soft tissue or bone sarcoma.
Dinçol D; Samur M; Pamir A; Sencan O; Akbulut H; Yalçin B; Onur H; Demirkazik A; Senler FC; Içli F
Cancer; 2000 May; 88(9):2033-6. PubMed ID: 10813713
[TBL] [Abstract][Full Text] [Related]
12. Increased levels of multiple forms of dihydrofolate reductase in peripheral blood leucocytes of cancer patients receiving haematopoietic colony-stimulating factors: interim analysis.
Iqbal MP; Burney IA; Sultana F; Mehboobali N; Siddiqui T
Exp Mol Med; 2000 Jun; 32(2):84-7. PubMed ID: 10926120
[TBL] [Abstract][Full Text] [Related]
13. Granulocyte-macrophage colony-stimulating factor in patients with neutropenic fever is potent after low-risk but not after high-risk neutropenic chemotherapy regimens: results of a randomized phase III trial.
Ravaud A; Chevreau C; Cany L; Houyau P; Dohollou N; Roché H; Soubeyran P; Bonichon F; Mihura J; Eghbali H; Tabah I; Bui BN
J Clin Oncol; 1998 Sep; 16(9):2930-6. PubMed ID: 9738560
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte and granulocyte-macrophage colony-stimulating factors in cord and maternal serum at delivery.
Bailie KE; Irvine AE; Bridges JM; McClure BG
Pediatr Res; 1994 Feb; 35(2):164-8. PubMed ID: 7513077
[TBL] [Abstract][Full Text] [Related]
15. Circadian rhythm of granulocyte-macrophage colony-stimulating factor in normal subjects and neutropenic hospitalised patients.
Abdelaal MA; Hashim IA; Zawawi TH; Felimban SK; Sobhi EM; Jeje O; Oni GA
Ir J Med Sci; 2000; 169(1):55-7. PubMed ID: 10846861
[TBL] [Abstract][Full Text] [Related]
16. Hematopoietic growth factors in colorectal cancer patients.
Mroczko B; Szmitkowski M; Okulczyk B
Clin Chem Lab Med; 2003 May; 41(5):646-51. PubMed ID: 12812262
[TBL] [Abstract][Full Text] [Related]
17. Lack of benefit of granulocyte macrophage or granulocyte colony stimulating factor in patients with febrile neutropenia.
Siddiqui T; Burney IA; Kakepoto GN; Khurshid M; Salam A; Smego RA
J Pak Med Assoc; 2002 May; 52(5):206-10. PubMed ID: 12174492
[TBL] [Abstract][Full Text] [Related]
18. [The plasma levels and diagnostic utility of selected hematopoietic growth factors (HGFs) in breast cancer patients].
Ławicki S; Czygier M; Wojtukiewicz M; Szmitkowski M
Przegl Lek; 2010; 67(12):1314-8. PubMed ID: 21591359
[TBL] [Abstract][Full Text] [Related]
19. An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients.
Engel A; Mack E; Kern P; Kern WV
Infection; 1998; 26(4):213-21. PubMed ID: 9717678
[TBL] [Abstract][Full Text] [Related]
20. Cytokine concentrations are not predictive of bacteremia in febrile neutropenic patients.
Buyukberber N; Buyukberber S; Sevinc A; Camci C
Med Oncol; 2009; 26(1):55-61. PubMed ID: 18686048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
